<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180627040252N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-06-17</date_registration>
      <primary_sponsor>Yazd University of Medical Sciences</primary_sponsor>
      <public_title>Surgiwrap in tendon repair</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of Extensor tendon repair methods with surgiwrap and without surgiwrap, as regards the rate of adhesion in patients with hand extensor tendon injury</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-09-03</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/56652</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients entered the study after obtaining informed consent until reaching the final specified sample size (80 tendon samples).
The sample size was 40 patients for 95% confidence level and 80% test power and 9.1 standard deviations for the main outcome of the motion difference. Because most patients had rupture of several extensor tendons; 80 specimens of extensor tendons were considered except for the thumb extensors.
Each patient participating in the study was assigned to two intervention groups using block randomisation until the extensor tendon sample size was completed in a ratio of 1: 1, Blinding description: In this study, all participants are aware of participating in this study and enter the study with their consent. participants are unaware of which group of this study they are in. The lead researcher, health care personnel, data collection officials, and those who evaluate the outcome are aware of the grouping of patients. Those who prepare the draft of the article are unaware of the groupings if they do not cooperate in the above cases.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Laceration of extensor muscle, fascia or tendon of other finger at wrist or hand level.</hc_freetext>
      <i_freetext>Intervention 1: Control group: Patients were referred to the operating room of the hospital for surgery and after randomly assigning them to the two intervention groups by operating room admission, in both groups (control and intervention) the standard treatment method (SOC) is as follows: Patients undergo local anaesthesia (5% lidocaine) and initial repair, and an arm tourniquet is used. Wounds are examined and washed with normal saline and the tendons cut are repaired by a surgeon with Prolen 3.0 and end-to-end running (SOC) method. The skin is then wrapped in nylon 5.0. All patients' hands are immobilized for 3 to 6 weeks (4 weeks) by static splint in the position of 40-45 degrees of extension in the wrist, 20 degrees of flexion in the metacarpophalangeal joint, and zero degrees of flexion of the interphalangeal joints to protect the repair site. From there, the protected active movement begins. Intervention 2: Intervention group: Patients were referred to the operating room of the hospital for surgery and after randomly assigning them to the two intervention groups by operating room admission, in both groups (control and intervention) the standard treatment method (SOC) is as follows: Patients undergo local anaesthesia (5% lidocaine) and initial repair, and an arm tourniquet is used. Wounds are examined and washed with normal saline and the tendons cut are repaired by a surgeon with Prolen 3.0 and end-to-end running (SOC) method. In the intervention group (SOC + S) after tendon repair, (Barrier (Surgiwrap) is placed between the skin and tendon and is sewn on 4 sides of the tendon with 05 sutures. so that, each side cover one centimetre more than the repair site. The skin is then wrapped in nylon 5.0. All patients' hands are immobilized for 3 to 6 weeks (4 weeks) by static splint in the position of 40-45 degrees of extension in the wrist, 20 degrees of flexion in the metacarpophalangeal joint, and zero degrees of flexion of the interphalangeal joints to protect the repair site. From there, the protected active movement begins.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Researchers have not yet decided on information sharing.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Morteza Rezaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Office of the Surgery Group, Shahid Mohammadi Hospital, Boulevard of the Islamic Republic of Iran, Bandar Abbas</address>
        <city>Bandar Abbas</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7916613885</zip>
        <telephone>+98 912 063 5468</telephone>
        <email>rezaie.mortaza@yahoo.com</email>
        <affiliation>Bandare-abbas University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Abbas Abdoli Tafti</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Sadougi hospital, Ebne Sina street, Shahid Ghandi BLvd</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8916886938</zip>
        <telephone>+98 35 3822 4000</telephone>
        <email>aabdoli2000@yahoo.com</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Zone 6 extensor tendon injury
Ability to repair the tendon directly and without shortening
Surgical repair indication
Completion of informed consent</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with uncontrolled diabetes
Multiple injuries
Simultaneous rupture of flexors with nerves and arteries
Inability to direct repair
Metacarpal fracture
Crush injury</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>NC57.31</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Laceration of extensor muscle, fascia or tendon of other finger at wrist or hand level</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: Patients were referred to the operating room of the hospital for surgery and after randomly assigning them to the two intervention groups by operating room admission, in both groups (control and intervention) the standard treatment method (SOC) is as follows: Patients undergo local anaesthesia (5% lidocaine) and initial repair, and an arm tourniquet is used. Wounds are examined and washed with normal saline and the tendons cut are repaired by a surgeon with Prolen 3.0 and end-to-end running (SOC) method. The skin is then wrapped in nylon 5.0. All patients' hands are immobilized for 3 to 6 weeks (4 weeks) by static splint in the position of 40-45 degrees of extension in the wrist, 20 degrees of flexion in the metacarpophalangeal joint, and zero degrees of flexion of the interphalangeal joints to protect the repair site. From there, the protected active movement begins.</i_keyword>
      <i_keyword>Intervention group: Patients were referred to the operating room of the hospital for surgery and after randomly assigning them to the two intervention groups by operating room admission, in both groups (control and intervention) the standard treatment method (SOC) is as follows: Patients undergo local anaesthesia (5% lidocaine) and initial repair, and an arm tourniquet is used. Wounds are examined and washed with normal saline and the tendons cut are repaired by a surgeon with Prolen 3.0 and end-to-end running (SOC) method. In the intervention group (SOC + S) after tendon repair, (Barrier (Surgiwrap) is placed between the skin and tendon and is sewn on 4 sides of the tendon with 05 sutures. so that, each side cover one centimetre more than the repair site. The skin is then wrapped in nylon 5.0. All patients' hands are immobilized for 3 to 6 weeks (4 weeks) by static splint in the position of 40-45 degrees of extension in the wrist, 20 degrees of flexion in the metacarpophalangeal joint, and zero degrees of flexion of the interphalangeal joints to protect the repair site. From there, the protected active movement begins.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Tendon adhesion. Timepoint: At the first visit and in the third, sixth and twelfth weeks after splint removal. Method of measurement: Miller’s scoring system.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Yazd University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-09-01</approval_date>
        <contact_name>Research Ethics Committees of School of Medicine- Shahid Sadoughi University of Medical Sciences</contact_name>
        <contact_address>Bahonar Square Yazd Yazd Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
